{"id":"W2151669647","doi":"10.2337/dc08-s258","title":"Efficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese Patients","year":2008,"lang":"en","type":"article","venue":"Diabetes Care","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval","funders":"Fonds Wetenschappelijk Onderzoek; GlaxoSmithKline; Vlaamse regering; Pfizer; AstraZeneca; Eli Lilly and Company; Pfizer Canada; Novo Nordisk; Sanofi; Abbott Laboratories","keywords":"Rimonabant; Medicine; Overweight; Type 2 diabetes; Dyslipidemia; Internal medicine; Population; Diabetes mellitus; Placebo; Metformin; Body mass index; Weight loss; Obesity; Endocrinology; Antagonist; Environmental health; Cannabinoid receptor","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006968763,0.00101902,0.003025626,0.0006097784,0.0001984062,0.0009764666,0.0004181845,0.0007537528,0.001118041],"category_scores_gemma":[0.006282476,0.0003528306,0.003347446,0.0005092242,0.0003339085,0.0006204356,0.0004432208,0.001023212,0.0001614928],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004146387,"about_ca_system_score_gemma":0.0005343275,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001959198,"about_ca_topic_score_gemma":0.0004521852,"domain_scores_codex":[0.9976797,0.001265206,0.0003888089,0.0002685977,0.0002907049,0.0001071509],"domain_scores_gemma":[0.9967383,0.001059277,0.001609991,0.0001808462,0.0002294887,0.0001821768],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5633581,0.003538163,0.124889,0.006361631,0.05566628,0.0003274271,0.0002115289,0.002848268,0.01881226,0.0001723681,0.001224573,0.2225903],"study_design_scores_gemma":[0.2070568,0.1501865,0.5580664,0.001129857,0.06213941,0.001429985,0.0002687377,0.004560609,0.01021281,0.0004762965,0.004319247,0.0001533875],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.936781,0.05819879,0.00124838,0.0003318141,0.0001001832,0.0005497388,0.0007810666,0.00006171599,0.001947389],"genre_scores_gemma":[0.9909763,0.006169696,0.001081748,0.0003268779,0.0002063025,0.000314021,0.0007374074,0.0000113672,0.0001763502],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006968763,"threshold_uncertainty_score":0.0368548,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01037209073205895,"score_gpt":0.2510864057302986,"score_spread":0.2407143149982396,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}